Home › Funds › Parkman Healthcare Partners LLC › GPCR
Parkman Healthcare Partners LLC position in GPCR
STRUCTURE THERAPEUTICS INC · Health Care
Parkman Healthcare Partners LLC reported holding 283,763 shares of GPCR (STRUCTURE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$8.9M, representing 0.80% of its reported portfolio and ranking #48 among its reported holdings. Parkman Healthcare Partners LLC has disclosed GPCR holdings in 6 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Parkman Healthcare Partners LLC's GPCR position evolved
Parkman Healthcare Partners LLC first disclosed a stake in GPCR in Q3 2023 at 30,000 shares (US$1.5M). The position peaked in Q2 2026 at 485,661 shares, worth US$26.1M. Across 6 filings, Parkman Healthcare Partners LLC increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 283,763 shares valued at US$8.9M — a reduction of -201,898 shares quarter over quarter.. Notable position changes include a 322% increase in Q1 2026 (shares rose 11% over the following quarter), a 109% increase in Q2 2026 (shares fell 42% over the following quarter), a 42% trim in Q3 2026 (shares fell 36% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 30.00K | $1.51M | New |
| Q4 2023 | 38.68K | $1.58M | Add |
| Q4 2025 | 55.00K | $3.83M | New |
| Q1 2026 | 232.09K | $11.19M | Add |
| Q2 2026 | 485.66K | $26.07M | Add |
| Q3 2026 | 283.76K | $8.87M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GPCR and 13F data
GPCR (STRUCTURE THERAPEUTICS INC) is a Health Care company. 26 other funds we track also report a position in GPCR — the largest reported positions include Avoro Capital Advisors LLC (US$205.0M), BVF INC/IL (US$180.7M), Deep Track Capital, LP (US$156.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GPCR
- Avoro Capital Advisors LLC 6.56M sh · $204.99M · Q3 2026
- BVF INC/IL 3.37M sh · $180.70M · Q2 2026
- Deep Track Capital, LP 5.00M sh · $156.35M · Q3 2026
- ORBIMED ADVISORS LLC 2.21M sh · $118.58M · Q2 2026
- BAKER BROS. ADVISORS LP 1.43M sh · $76.88M · Q2 2026
- RTW INVESTMENTS, LP 2.28M sh · $71.36M · Q3 2026
- Casdin Capital 1.18M sh · $63.06M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.09M sh · $58.29M · Q2 2026
- Paradigm Biocapital Advisors LP 1.30M sh · $40.63M · Q3 2026
- Logos Global Management LP 1.00M sh · $31.27M · Q3 2026
- Siren, L.L.C. 872.97K sh · $27.30M · Q3 2026
- PACIFIC HEIGHTS ASSET MANAGEMENT LLC 800.00K sh · $25.02M · Q3 2026
More on Parkman Healthcare Partners LLC
FAQ
How long has Parkman Healthcare Partners LLC held GPCR?
Parkman Healthcare Partners LLC has disclosed GPCR holdings in 6 of the last 13 reported quarters, going back to Q3 2023.
What is Parkman Healthcare Partners LLC's current position in GPCR?
As of Q3 2026, Parkman Healthcare Partners LLC holds 283.76K shares of GPCR (STRUCTURE THERAPEUTICS INC), valued at $8.87M, representing 0.80% of its reported portfolio and ranking #48.
Has Parkman Healthcare Partners LLC been buying or selling GPCR?
In the latest 13F filing (Q3 2026), Parkman Healthcare Partners LLC reduced its position in GPCR. The position peaked in Q2 2026 at 485.66K shares.
Which other funds hold GPCR?
Other major institutional holders of GPCR include Avoro Capital Advisors LLC, BVF INC/IL, Deep Track Capital, LP, among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.